Not Medicare Enrolled
Dr. Mark Campbell, MD
Medical Oncology · Grand Rapids, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Campbell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Campbell?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Campbell
Dr. Mark Campbell is a medical oncology specialist in Grand Rapids, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Campbell performed 3,477 Medicare services across 1,074 unique beneficiaries.
Between the years covered by Open Payments, Dr. Campbell received a total of $7,896 from 63 pharmaceutical and/or device companies across 482 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Campbell is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 31% volume in MI
$7,896 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,477
Medicare services
Top 31% in MI for medical oncology
1,074
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~174 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
535 | $8 | $14 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
505 | $7 | $26 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
456 | $10 | $35 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
372 | $0 | $1 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 220 | $132 | $354 |
| PSA test (prostate cancer screening) | 193 | $18 | $63 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
127 | $69 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
126 | $88 | $189 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
96 | $60 | $133 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
89 | $6 | $25 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
79 | $16 | $57 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
69 | $23 | $72 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
68 | $6 | $23 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
64 | $88 | $292 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
60 | $11 | $34 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
48 | $17 | $65 |
| Adrenocorticotropic hormone (ACTH) level test A blood test that measures the amount of adrenocorticotropic hormone in your body. |
44 | $38 | $108 |
| Total cortisol level test A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands. |
44 | $16 | $46 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
44 | $4 | $13 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
36 | $10 | $38 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
30 | $25 | $88 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
20 | $13 | $46 |
| Iron level test | 20 | $6 | $22 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 20 | $20 | $71 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $40 | $82 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
18 | $39 | $151 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
16 | $12 | $40 |
| Hepatitis B surface antigen test A blood test that uses an immunoassay technique to detect the presence of the hepatitis B surface antigen. This test identifies whether the hepatitis B virus is currently present in the body. |
16 | $10 | $26 |
| Hepatitis B core antibody test A blood test that measures the level of antibodies to the hepatitis B core antigen. This test helps determine if a person has been infected with the hepatitis B virus. |
15 | $11 | $30 |
| Hepatitis B surface antibody test A blood test that measures the level of antibodies against the hepatitis B surface antigen. This test is used to check for immunity to hepatitis B or to verify the effectiveness of the hepatitis B vaccine. |
15 | $10 | $27 |
| New patient office visit, complex (60-74 min) | 13 | $157 | $324 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.4% high complexity
18.0% medium
79.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,896
Total received (2018-2024)
Avg $1,128/year across 7 years
Top 32% in MI for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
482
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,639 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$257 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$398
2023
$956
2022
$1,427
2021
$136
2020
$439
2019
$2,149
2018
$2,391
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$101
Celgene Corporation
$66
Novartis Pharmaceuticals Corporation
$52
Eisai Inc.
$34
ABBVIE INC.
$25
Genentech USA, Inc.
$24
TerSera Therapeutics LLC
$18
Daiichi Sankyo Inc.
$18
EMD Serono, Inc.
$16
PFIZER INC.
$16
Janssen Biotech, Inc.
$15
Astellas Pharma US Inc
$13
Top 3 companies account for 55.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$599
Novartis Pharmaceuticals Corporation
$554
Janssen Biotech, Inc.
$545
PFIZER INC.
$520
Amgen Inc.
$487
Genentech USA, Inc.
$479
Celgene Corporation
$313
Ipsen Biopharmaceuticals, Inc
$235
E.R. Squibb & Sons, L.L.C.
$234
Merck Sharp & Dohme Corporation
$233
EISAI INC.
$230
Astellas Pharma US Inc
$229
Takeda Pharmaceuticals U.S.A., Inc.
$203
Bayer HealthCare Pharmaceuticals Inc.
$197
EMD Serono, Inc.
$188
Gilead Sciences, Inc.
$185
Lilly USA, LLC
$184
GENZYME CORPORATION
$151
Daiichi Sankyo Inc.
$135
TESARO, Inc.
$133
Incyte Corporation
$115
Pharmacyclics LLC, An AbbVie Company
$110
Eisai Inc.
$100
Seagen Inc.
$99
Jazz Pharmaceuticals Inc.
$95
Merck Sharp & Dohme LLC
$87
Foundation Medicine, Inc.
$78
Pharmacyclics LLC, an AbbVie Company
$74
Regeneron Healthcare Solutions, Inc.
$72
ADC Therapeutics America, Inc.
$56
Myovant Sciences Inc.
$56
AbbVie, Inc.
$55
Alexion Pharmaceuticals, Inc.
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
Exelixis Inc.
$50
AbbVie Inc.
$46
TerSera Therapeutics LLC
$46
Deciphera Pharmaceuticals Inc.
$44
Spectrum Pharmaceuticals Inc.
$44
Rigel Pharmaceuticals, Inc.
$44
Karyopharm Therapeutics Inc.
$38
Janssen Pharmaceuticals, Inc
$33
Mylan Institutional Inc.
$31
Kite Pharma, Inc.
$31
Lexicon Pharmaceuticals, Inc.
$25
ABBVIE INC.
$25
Agios Pharmaceuticals, Inc.
$24
GlaxoSmithKline, LLC.
$23
Bristol-Myers Squibb Company
$23
Clovis Oncology, Inc.
$21
Acrotech Biopharma LLC
$21
JAZZ PHARMACEUTICALS INC.
$21
Adaptive Biotechnologies Corporation
$21
Coherus Biosciences Inc.
$20
Stemline Therapeutics Inc.
$19
Heron Therapeutics, Inc.
$17
Sumitomo Pharma America, Inc.
$16
Midatech Pharma US Inc
$14
SERVIER PHARMACEUTICALS LLC
$14
INSYS Therapeutics Inc
$13
Seattle Genetics, Inc.
$12
Puma Biotechnology, Inc.
$12
Verastem, Inc.
$12
Top 3 companies account for 21.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · Abraxane · Actemra · Alecensa · BALVERSA · BAVENCIO · BOSULIF · Balversa · Bavencio · Blincyto · CABLIVI · CALQUENCE · CINVANTI · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELIQUIS · EMPLICITI · ENHERTU · ERLEADA · Enhertu · Erleada · FASLODEX · FOLOTYN · FOUNDATIONONE · Folotyn · Fulphila · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Gelclair · Halaven · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · MYLOTARG · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OPDIVO · ORGOVYX · Ogivri · Orserdu · PADCEV · PLUVICTO · PREVYMIS · PROMACTA · PROSTATE CANCER - DISEASE · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · ROZLYTREK · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tazverik · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · Zoladex · Zydelig · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical oncologists within 10 mi
11
Per 100K population
1.7
County median income
$80,390
Nearest hospital
SPECTRUM HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Campbell is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Campbell experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Campbell performed 535 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Campbell receive payments from pharmaceutical companies?
Yes. Dr. Campbell received a total of $7,896 from 63 companies across 482 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Campbell's costs compare to other medical oncologists in Grand Rapids?
Dr. Campbell's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Campbell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Grand Rapids
Browse medical oncologists in Grand Rapids ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in MI
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in MI
Which MI medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology